Seattle-based biotech Omeros Corp. (Nasdaq: OMER) is selling its Omidria franchise to the British eye care company Rayner Surgical Group Ltd.
News
- Seattle biotech Omeros selling drug franchise in deal valued at over $1B - The Business Journals
- Omicron identified in US after dramatic improvement in genome sequencing | KABB
“This state, after all, is the birthplace of biotech, of life sciences.” A couple stand outside the security control section inside a terminal of ...
- Rebecca Viagran, former San Antonio City Councilwoman, may make a bid for open ...
San Antonio's former South Side city councilwoman Rebecca Viagran is “seriously considering” a run for congress, she said on Thursday.
- Houston Inno - K2 BioLabs hiring, expanding contract research offerings for biotech, pharma startups
The 28345-square-foot K2bio facility was designed to offer turnkey services to early-stage biotech and pharmaceutical companies working products ...
- Compound shows promise for minimizing erratic movements in Parkinson's patients - Mega ...
Newswise — SAN ANTONIO – A new study from Texas Biomedical Research Institute (Texas Biomed) and collaborators has identified a promising drug ...